Brief: Renovorx Inc - On Oct 31, Co Received Formal Notice, The Staff Of The Nasdaq Had Granted The Co’S Request For Continued Listing On Nasdaq
Nov 6 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX INC - ON OCT 31, CO RECEIVED FORMAL NOTICE, THE
STAFF
OF THE NASDAQ HAD GRANTED THE CO’S REQUEST FOR CONTINUED LISTING
ON NASDAQ
Source text for Eikon: ID:
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies